RMTI icon

Rockwell Medical

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 63.6%
Negative

Neutral
Business Wire
12 days ago
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis products.
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
Neutral
Business Wire
18 days ago
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including PureCart, RenalPure, SteriLyte and other products.
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
Neutral
Seeking Alpha
24 days ago
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Negative
Zacks Investment Research
25 days ago
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
Rockwell Medical (RMTI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.04 per share a year ago.
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
Neutral
Business Wire
25 days ago
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical 2026 Guidance is centered around strengthening revenue, expanding gross margin, and generating positive Adjusted EBITDA and cash flow.
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
Neutral
Business Wire
1 month ago
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026.
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
Positive
Zacks Investment Research
2 months ago
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
Positive
Zacks Investment Research
2 months ago
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
Neutral
Seeking Alpha
2 months ago
Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates
Rockwell Medical (RMTI) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $0.02 per share a year ago.
Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates